Holen Sie sich die Stockscreener-App
17.60
1.57%
-0.28
Vorhandelsmarkt:
17.50
-0.10
-0.57%
Schlusskurs vom Vortag:
$17.88
Offen:
$17.83
24-Stunden-Volumen:
1.66M
Relative Volume:
0.64
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-8.19%
1M Leistung:
-10.02%
6M Leistung:
-71.75%
1J Leistung:
-73.33%
1-Tages-Spanne:
$17.02
$18.03
1-Wochen-Bereich:
$16.25
$19.41
52-Wochen-Spanne:
$16.25
$160.50
Direxion Daily S P Biotech Bear 3 X Shares Stock (LABD) Company Profile
Firmenname
Direxion Daily S P Biotech Bear 3 X Shares
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie LABD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LABD
Direxion Daily S P Biotech Bear 3 X Shares
|
17.60 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
343.27 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
695.49 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
698.65 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
274.07 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
631.13 | 124.43B | 0 | 0 | 0 | 0.00 |
Direxion Daily S P Biotech Bear 3 X Shares Aktie (LABD) Neueste Nachrichten
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD) - Seeking Alpha
GUSH: Examining The Structure And Suitability Of This 2X Leveraged ETF (NYSEARCA: GUSH) - Seeking Alpha
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF (NYSEARCA:LABU) - Seeking Alpha
NAIL: Favorable Macroeconomic Outlook For 2026-2027 (NYSEARCA:NAIL) - Seeking Alpha
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF (NYSEARCA:CURE) - Seeking Alpha
Behavioral Patterns of LABD and Institutional Flows - Stock Traders Daily
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026 - 24/7 Wall St.
Short Interest in Direxion Daily BRKB Bull 2X Shares (NASDAQ:BRKU) Drops By 40.8% - MarketBeat
Direxion Daily GOOGL Bull 2X Shares (NASDAQ:GGLL) Hits New 52-Week HighTime to Buy? - MarketBeat
Direxion Daily MU Bull 2X Shares (NASDAQ:MUU) Short Interest Down 73.4% in December - MarketBeat
Direxion Daily TSM Bull 2X Shares (NASDAQ:TSMX) Short Interest Update - MarketBeat
Earn 8% and (Potentially) 3x the S&P’s Return This Year, but There Is a Catch - 24/7 Wall St.
Bet Against Big Banks in 2026 With FAZ - 24/7 Wall St.
The 2X Long INTC (INTW) fund rose by 13.10% with a trading value of $111.98 million. - Sahm
Direxion Daily GOOGL Bull 2X Shares (NASDAQ:GGLL) Shares Gap UpStill a Buy? - MarketBeat
Q4 Earnings: Beat, Miss, or Market Whiplash? - Direxion
Direxion Daily Natural Gas Related Bear 3x Shares Direxion Shares ETF Trust - GuruFocus
(LABD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Direxion’s Aerospace & Defense ETF Is Up Almost 150% - 24/7 Wall St.
Direxion Daily MU Bull 2X Shares (NASDAQ:MUU) Short Interest Up 51.8% in December - MarketBeat
Direxion Daily TSM Bull 2X Shares (NASDAQ:TSMX) Short Interest Down 38.3% in December - MarketBeat
Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.2287 - MSN
Why (LABD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Direxion Daily BRKB Bull 2X Shares (NASDAQ:BRKU) Declares Quarterly Dividend of $0.21 - MarketBeat
Direxion Daily MSFT Bull 2X Shares (NASDAQ:MSFU) Declares $0.27 Quarterly Dividend - MarketBeat
Direxion Daily AVGO Bull 2X Shares (NASDAQ:AVL) Announces $0.16 Quarterly Dividend - MarketBeat
Direxion Daily GOOGL Bull 2X Shares (NASDAQ:GGLL) Announces Quarterly Dividend of $0.34 - MarketBeat
RDVY First Trust Rising Dividend 69.90$ +0.68%eToro - eToro
RS2K.PA Amundi Russell 2000 UCITS ETF 323.10€ +1.47%eToro - eToro
How to Trade Biotech’s Volatility with LABU/LABD | CRISPR & Cancer Stocks - ETFguide
Oil Nears A Rough End To 2025, But These Energy ETFs Can Keep Traders In The Game - Benzinga
(LABD) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
CURE: The Leveraged ETF That Turbocharges The Leading U.S. Healthcare Stocks (CURE) - Seeking Alpha
5 Small-cap Biotech ETFs to Watch - Investing News Network
TSLL Stock Outlook: Is Direxion’s 2X Tesla ETF Still Worth the Risk After December’s Rally? - TechStock²
(LABD) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
TNA: Small Caps Could Benefit From U.S. Economy Uptick In 2026 (NYSEARCA:TNA) - Seeking Alpha
CURE: Analysts Strike A Cautious Tone Heading Into 2026 (NYSEARCA:CURE) - Seeking Alpha
(LABD) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
TECL: Risks And Rewards Of The Leveraged Bull (TECL) - Seeking Alpha
Top Performing Leveraged/Inverse ETFs: 11/16/2025 - ETF Database
Direxion Daily GOOGL Bull 2X Shares (NASDAQ:GGLL) Sets New 1-Year HighWhat's Next? - MarketBeat
3 Reasons FIVN is Risky and 1 Stock to Buy Instead - Barchart.com
3 Reasons We Love Meta (META) - Barchart.com
Direxion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.1027 - MSN
2 Reasons to Avoid FI and 1 Stock to Buy Instead - Barchart.com
Direxion Daily S&P Biotech Bear 3x Shares ETF - 富途牛牛
(LABD) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Semrush (SEMR) Stock Is Up, What You Need To Know - Barchart.com
FAS: Understanding The Leveraged Financial ETF (NYSEARCA:FAS) - Seeking Alpha
Best Stocks Under $50 Right Now - Benzinga
Finanzdaten der Direxion Daily S P Biotech Bear 3 X Shares-Aktie (LABD)
Es liegen keine Finanzdaten für Direxion Daily S P Biotech Bear 3 X Shares (LABD) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.03%
0.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):